2016/07/27

Completion of series B funding round.

2016/06/27

A new study using our TCR repertoire analysis was published online in "Cancer Immunology Research."

2016/06/13

Our collaborator presented a new study using our next generation BCR analysis at the ASCO 2016 Annual Meeting.

2016/06/01

Partnership with RIKEN GENESIS Co., Ltd. to provide TCR/BCR repertoire analysis services with the quality of international standards.

2016/04/01

Ryuji Suzuki was appointed as new CEO.

2016/03/31

Posting our article on the April issue of Nature's MedTech Dealmakers.

2016/02/15

Repertoire Genesis, Inc. has been selected for the Innovative Showcase Company at Biocom's conference.

2015/11/20

Our collaborators to present a new study at the American Society of Hematology Annual Meeting.

2015/08/18

Repertoire Genesis, Inc. has been selected for the Innovation Showcase at AdvaMed 2015

2015/07/22

New study using our next generation TCR analysis was awarded a "Young Investigator Award"